Appropriate Use of Insulin Analogs in an Increasingly Complex Type 2 Diabetes Mellitus (T2DM) Therapeutic Landscape

CME/CNE 0.75 AMA PRA Category 1 Credit(s)™

Presented by
Thomas M. Flood, MD, FACE
Author information

Sponsor Information
This activity is jointly sponsored by Embryon and Medical Education Collaborative (MEC). MEC is a nonprofit organization that has been certifying quality educational activities since 1988.

Purpose Statement
The purpose of this project is to provide a vehicle for educating a large number of family practice physicians about the role and appropriate use of insulin analogs.

Release date: January 2007
Expiration date: January 2008

Target Audience
Primary care practitoners (PCP)/General/Family practitioners

Learning Objectives
• Discuss the benefits that the appropriate insulin analogs provide when treating fasting and postprandial hyperglycemia
• Categorically present the various treatment options that are available for T2DM
• Present advantages and disadvantages of the various therapeutic options and what they address (i.e. fasting or postprandial hyperglycemia)
• Present studies that address combination therapies of insulin with newer agents with available data

CME information

Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Medical Education Collaborative, Inc. (MEC) and Embryon. MEC is accredited by the ACCME to provide continuing medical education for physicians.

Medical Education Collaborative designates this educational activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)^™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

For questions regarding the accreditation of this activity, please contact Medical Education Collaborative at (303) 420-3252 or email: inquire@meccme.org.

Instructions for Credit
In order to receive credit, participants must score at least a 70% on the posttest and submit it along with the credit application and evaluation form to the address/fax number indicated. Statements of credit will be mailed within 6 to 8 weeks following the program.

Commercial Support Information

This activity was made possible by an educational grant from sanofi-aventis U.S.

Disclosures
The presenter of this program, Thomas Flood, MD, has disclosed the following relationships: Speaker for sanofi-aventis U.S., Pfizer Inc, and GlaxoSmithKline.

Employees of Medical Education Collaborative, the accredited provider for this activity, have disclosed that they have no significant financial relationships.